Skip to main content
. Author manuscript; available in PMC: 2012 Dec 19.
Published in final edited form as: J Nucl Med. 2012 Feb 17;53(4):538–545. doi: 10.2967/jnumed.111.096032

Figure 2.

Figure 2

58-year-old male with prostate cancer. Axial T2-weighted MRI (A) demonstrates a low signal intensity focus in the right mid gland peripheral zone (white arrow), which shows 11C-Acetate uptake in the axial PET image (black arrow) (B). Fused 11C-Acetate PET/MRI (C) better localizes the tumor (black arrow). Corresponding pathology shows a Gleason 3+4 tumor in the right mid-peripheral zone (inked in black) (D).